Generic Drug Labeling

Witnesses testified at a hearing on the Food and Drug Administration’s FDA’s proposal to have generic drug makers update their safety labels… read more

Witnesses testified at a hearing on the Food and Drug Administration’s FDA’s proposal to have generic drug makers update their safety labels as soon as the information becomes available. At the time of this hearing, generic brands could not update labels unless the original developer did so. Some lawmakers expressed concern that the rule change could create contradictory labels for the same medicine. FDA official in charge of drug evaluation and research Janet Woodcock testified the first panel. In a separate panel, the subcommittee also heard from the president of the Generic Pharmaceutical Association. close

Report Video Issue

People in this video

More People

Hosting Organization

More information about

Generic Drug Labeling

580 Views
Program ID:
318627-1
Category:
House Committee
Format:
House Committee
Location:
Washington, District of Columbia, United States
First Aired:
Apr 01, 2014 | 3:00pm EDT | C-SPAN.org
Last Aired:
Apr 16, 2014 | 11:34am EDT | C-SPAN 3

Airing Details

  • Apr 04, 2014 | 9:54pm EDT | C-SPAN 3
  • Apr 05, 2014 | 3:54am EDT | C-SPAN 3
  • Apr 16, 2014 | 11:34am EDT | C-SPAN 3
Purchase a Download

Generic Drug Labeling

  • MP4 video - Standard
    Price:
    $9.99 or Free with MyC‑SPAN
  • MP3 audio - Standard
    Price:
    $0.99

User Created Clips from This Video